載入...
Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension
BACKGROUND: Previous clinical trials with birch pollen subcutaneous immunotherapy have been conducted over a 1‐ to 2‐year treatment period and involved mostly a single geographic location. OBJECTIVE: This study (EudraCT‐Number: 2005‐000025‐35) intended to evaluate the effect of subcutaneous immunoth...
Na minha lista:
| 發表在: | Clin Exp Allergy |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849700/ https://ncbi.nlm.nih.gov/pubmed/30570787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cea.13331 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|